225 related articles for article (PubMed ID: 26056141)
1. Erbin is a novel substrate of the Sag-βTrCP E3 ligase that regulates KrasG12D-induced skin tumorigenesis.
Xie CM; Wei D; Zhao L; Marchetto S; Mei L; Borg JP; Sun Y
J Cell Biol; 2015 Jun; 209(5):721-37. PubMed ID: 26056141
[TBL] [Abstract][Full Text] [Related]
2. Inactivation of Sag/Rbx2/Roc2 e3 ubiquitin ligase triggers senescence and inhibits kras-induced immortalization.
Tan M; Li H; Sun Y
Neoplasia; 2015 Jan; 17(1):114-23. PubMed ID: 25622904
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of SAG/RBX2 E3 ubiquitin ligase suppresses KrasG12D-driven lung tumorigenesis.
Li H; Tan M; Jia L; Wei D; Zhao Y; Chen G; Xu J; Zhao L; Thomas D; Beer DG; Sun Y
J Clin Invest; 2014 Feb; 124(2):835-46. PubMed ID: 24430184
[TBL] [Abstract][Full Text] [Related]
4. Depletion of SAG/RBX2 E3 ubiquitin ligase suppresses prostate tumorigenesis via inactivation of the PI3K/AKT/mTOR axis.
Tan M; Xu J; Siddiqui J; Feng F; Sun Y
Mol Cancer; 2016 Dec; 15(1):81. PubMed ID: 27955654
[TBL] [Abstract][Full Text] [Related]
5. Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis.
DeNicola GM; Karreth FA; Humpton TJ; Gopinathan A; Wei C; Frese K; Mangal D; Yu KH; Yeo CJ; Calhoun ES; Scrimieri F; Winter JM; Hruban RH; Iacobuzio-Donahue C; Kern SE; Blair IA; Tuveson DA
Nature; 2011 Jul; 475(7354):106-9. PubMed ID: 21734707
[TBL] [Abstract][Full Text] [Related]
6. The Sag-Shoc2 axis regulates conversion of mPanINs to cystic lesions in Kras pancreatic tumor model.
Tan M; Chang Y; Liu X; Li H; Tang Z; Nyati MK; Sun Y
Cell Rep; 2022 Dec; 41(12):111837. PubMed ID: 36543126
[TBL] [Abstract][Full Text] [Related]
7. SAG/RBX2 E3 ligase complexes with UBCH10 and UBE2S E2s to ubiquitylate β-TrCP1 via K11-linkage for degradation.
Kuang P; Tan M; Zhou W; Zhang Q; Sun Y
Sci Rep; 2016 Dec; 6():37441. PubMed ID: 27910872
[TBL] [Abstract][Full Text] [Related]
8. Suppression of skin tumorigenesis in CD109-deficient mice.
Sunagawa M; Mii S; Enomoto A; Kato T; Murakumo Y; Shiraki Y; Asai N; Asai M; Nagino M; Takahashi M
Oncotarget; 2016 Dec; 7(50):82836-82850. PubMed ID: 27756876
[TBL] [Abstract][Full Text] [Related]
9. CD166 positively regulates MCAM via inhibition to ubiquitin E3 ligases Smurf1 and βTrCP through PI3K/AKT and c-Raf/MEK/ERK signaling in Bel-7402 hepatocellular carcinoma cells.
Tang X; Chen X; Xu Y; Qiao Y; Zhang X; Wang Y; Guan Y; Sun F; Wang J
Cell Signal; 2015 Sep; 27(9):1694-702. PubMed ID: 26004137
[TBL] [Abstract][Full Text] [Related]
10. SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB.
Gu Q; Bowden GT; Normolle D; Sun Y
J Cell Biol; 2007 Sep; 178(6):1009-23. PubMed ID: 17846172
[TBL] [Abstract][Full Text] [Related]
11. Endothelial deletion of Sag/Rbx2/Roc2 E3 ubiquitin ligase causes embryonic lethality and blocks tumor angiogenesis.
Tan M; Li H; Sun Y
Oncogene; 2014 Oct; 33(44):5211-20. PubMed ID: 24213570
[TBL] [Abstract][Full Text] [Related]
12. SAG/RBX2/ROC2 E3 ubiquitin ligase is essential for vascular and neural development by targeting NF1 for degradation.
Tan M; Zhao Y; Kim SJ; Liu M; Jia L; Saunders TL; Zhu Y; Sun Y
Dev Cell; 2011 Dec; 21(6):1062-76. PubMed ID: 22118770
[TBL] [Abstract][Full Text] [Related]
13. Functional characterization of SAG/RBX2/ROC2/RNF7, an antioxidant protein and an E3 ubiquitin ligase.
Sun Y; Li H
Protein Cell; 2013 Feb; 4(2):103-16. PubMed ID: 23136067
[TBL] [Abstract][Full Text] [Related]
14. Elevated FBXL6 activates both wild-type KRAS and mutant KRAS
Xiong HJ; Yu HQ; Zhang J; Fang L; Wu D; Lin XT; Xie CM
Mil Med Res; 2023 Dec; 10(1):68. PubMed ID: 38124228
[TBL] [Abstract][Full Text] [Related]
15. Unique dependence on Sos1 in
You X; Kong G; Ranheim EA; Yang D; Zhou Y; Zhang J
Blood; 2018 Dec; 132(24):2575-2579. PubMed ID: 30377195
[TBL] [Abstract][Full Text] [Related]
16. Transgenic expression of Sag/Rbx2 E3 causes early stage tumor promotion, late stage cytogenesis and acinar loss in the Kras-PDAC model.
Zhang Q; Wei D; Tan M; Li H; Morgan MA; Sun Y
Neoplasia; 2020 Apr; 22(6):242-252. PubMed ID: 32339950
[TBL] [Abstract][Full Text] [Related]
17. SAG/ROC2/Rbx2 is a novel activator protein-1 target that promotes c-Jun degradation and inhibits 12-O-tetradecanoylphorbol-13-acetate-induced neoplastic transformation.
Gu Q; Tan M; Sun Y
Cancer Res; 2007 Apr; 67(8):3616-25. PubMed ID: 17440073
[TBL] [Abstract][Full Text] [Related]
18. O-GlcNAcylation is required for mutant KRAS-induced lung tumorigenesis.
Taparra K; Wang H; Malek R; Lafargue A; Barbhuiya MA; Wang X; Simons BW; Ballew M; Nugent K; Groves J; Williams RD; Shiraishi T; Verdone J; Yildirir G; Henry R; Zhang B; Wong J; Wang KK; Nelkin BD; Pienta KJ; Felsher D; Zachara NE; Tran PT
J Clin Invest; 2018 Nov; 128(11):4924-4937. PubMed ID: 30130254
[TBL] [Abstract][Full Text] [Related]
19. Mule/Huwe1/Arf-BP1 suppresses Ras-driven tumorigenesis by preventing c-Myc/Miz1-mediated down-regulation of p21 and p15.
Inoue S; Hao Z; Elia AJ; Cescon D; Zhou L; Silvester J; Snow B; Harris IS; Sasaki M; Li WY; Itsumi M; Yamamoto K; Ueda T; Dominguez-Brauer C; Gorrini C; Chio II; Haight J; You-Ten A; McCracken S; Wakeham A; Ghazarian D; Penn LJ; Melino G; Mak TW
Genes Dev; 2013 May; 27(10):1101-14. PubMed ID: 23699408
[TBL] [Abstract][Full Text] [Related]
20. RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties.
Horn EJ; Albor A; Liu Y; El-Hizawi S; Vanderbeek GE; Babcock M; Bowden GT; Hennings H; Lozano G; Weinberg WC; Kulesz-Martin M
Carcinogenesis; 2004 Feb; 25(2):157-67. PubMed ID: 14578165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
